67 results
8-K
EX-10.1
BIAF
BioAffinity Technologies Inc
5 Jun 24
Departure of Directors or Certain Officers
4:10pm
prior to the Transaction continue to have a majority of the voting power in the resulting entity;
(iii) Within any 12-month period beginning … cease (for any reason other than death) to constitute at least a majority of the Board (or the board of directors of any successor to the Company
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
that make up the majority of the net working capital assumed in the acquisition. These values are subject to change as the Company performs additional … activities
Total operating loss
Non-operating income (expense), net
Net loss before income taxes
Income tax expense
Net loss
The majority
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
. The Company has determined the preliminary fair values of the accounts receivable, accounts payable, and accrued expenses that make up the majority … operating loss
Non-operating income (expense), net
Net loss before income taxes
Income tax expense
Net loss
The majority of the increase versus the prior
8-K
EX-99.1
BIAF
BioAffinity Technologies Inc
15 May 24
Results of Operations and Financial Condition
6:07pm
for the first quarter of 2024 was $2.4 million, compared with $921 revenue for the prior-year period. The majority of the year-over-year increase
424B3
zhxan
16 Apr 24
Prospectus supplement
7:19pm
POS AM
awrlb7eq8xbgf
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
8-K
EX-1.1
nnyahhha5jq5xhutvs
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.2
cws t4jjn2pdoz
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.1
inl x3ttl
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
xnx2 ticjcsfvksjxxt
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
424B5
6w8f2llrgqwz8mqxykx
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
r3e79 yczmhbwri6wzeo
7 Mar 24
Prospectus supplement for primary offering
9:57pm
424B5
63xm4kjbang8f e25uy
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
t9j agzle
16 Nov 23
Shelf registration
5:23pm